COMBINATION THERAPIES WITH ANTI-CD38 ANTIBODIES AND PARP OR ADENOSINE RECEPTOR INHIBITORS
This invention relates to methods and compositions for treating a disease by administering a combination therapy comprising an anti- CD38 antibody and a poly ADR ribose polymerase inhibitor (PARPi); an anti-CD38 antibody and an adenosine receptor antagonist; or an anti- CD38 antibody, a PARPi and an...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English Spanish |
Published |
14.11.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to methods and compositions for treating a disease by administering a combination therapy comprising an anti- CD38 antibody and a poly ADR ribose polymerase inhibitor (PARPi); an anti-CD38 antibody and an adenosine receptor antagonist; or an anti- CD38 antibody, a PARPi and an adenosine receptor antagonist, to a subject (e.g., a human patient) in need thereof.
Esta invención se relaciona con métodos y composiciones para tratar una enfermedad al administrar una terapia de combinación que comprende un anticuerpo anti-CD38 y un inhibidor de poli ADP ribosa polimerasa (PARPi); un anticuerpo anti-CD38 y un antagonista del receptor de adenosina o un anticuerpo anti-CD38, un PARPi y un antagonista del receptor de adenosina, a un sujeto (p. ej., un paciente humano) que lo necesite. |
---|---|
Bibliography: | Application Number: MX20230009769 |